Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures

CompletedOBSERVATIONAL
Enrollment

578

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
DexmedetomidineSedation
Interventions
DRUG

Intranasal dexmedetomidine

Intranasal dexemedetomidine (100 mcg/mL), 0.5 to 4 mcg/kg

Trial Locations (8)

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

27514

UNC Children's Hospital, Chapel Hill

30329

Children's Healthcare of Atlanta, Atlanta

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

62794

Southern Illinois University Healthcare, Springfield

77030

Texas Children's Hospital, Houston

95128

Santa Clara Valley Medical Center, San Jose

02115

Boston Children's Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Children's Healthcare of Atlanta

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

UNC Children's Hospital

UNKNOWN

collaborator

Santa Clara Valley Medical Center

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

HSHS St. John's Hospital

UNKNOWN

collaborator

Boston Children's Hospital

OTHER

lead

Columbia University

OTHER